The Dementia theme has 14 member stock(s) today, with an average return of -1.2%. The leading stock is 삼진제약 (+0.6%, trading value 334,786,470).
Degenerative brain disease diagnostics and treatments, drawing attention due to the opening of the novel dementia treatment market (such as lecanemab) and early diagnostic kit demand as society becomes super-aged.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 삼진제약 | 18,550 | +0.6% | 334,786,470 |
| 보로노이 | 145,400 | +0.2% | 9,779,290,000 |
| 브이티 | 11,740 | +0.1% | 1,747,358,180 |
| 명문제약 | 1,237 | -0.4% | 90,551,818 |
| 모나리자 | 1,451 | -0.6% | 184,121,672 |
| 환인제약 | 10,240 | -0.6% | 106,830,905 |
| 대웅제약 | 111,100 | -0.7% | 1,374,070,900 |
| 서린바이오 | 4,020 | -0.9% | 25,353,323 |
| 신신제약 | 4,495 | -1.4% | 90,868,485 |
| 대화제약 | 10,600 | -1.5% | 317,835,810 |
| 일진홀딩스 | 6,700 | -2.0% | 543,574,300 |
| 씨티씨바이오 | 3,020 | -2.6% | 90,423,020 |
| HLB제약 | 6,450 | -2.7% | 619,635,955 |
| 하이퍼코퍼레이션 | 1,540 | -4.6% | 18,058,833 |
This page's data is for reference only and is not investment advice. Actual market data may differ.